SeaSpine Holdings Corporation (NASDAQ:SPNE) Files An 8-K Results of Operations and Financial Condition
Item 2.02
|
Results of Operations and Financial Condition.
|
release announcing selected preliminary unaudited financial
results for the three-months and full-year ended December 31,
2016. A copy of this release is furnished as Exhibit 99.1 hereto.
|
Item 9.01
|
Financial Statements and Exhibits.
|
reference to the Exhibit Index immediately following the page of
this report.
not being filed for purposes of Section 18 of the Securities
Exchange Act of 1934 and is not to be incorporated by reference
into any filing of the registrant, whether made before or after
the date hereof, regardless of any general incorporation language
in any such filing.
About SeaSpine Holdings Corporation (NASDAQ:SPNE)
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures. SeaSpine Holdings Corporation (NASDAQ:SPNE) Recent Trading Information
SeaSpine Holdings Corporation (NASDAQ:SPNE) closed its last trading session down -0.23 at 7.16 with 10,652 shares trading hands.
